openPR Logo
Press release

AATD Augmentation Therapy Market: Grifols, S.A., Kamada Ltd, Shire plc (Baxalta), and CSL Limited. Grifols accounted for the highest share in terms of revenue in 2018

05-02-2019 08:42 AM CET | Health & Medicine

Press release from: Fortune Business Insights

AATD Augmentation Therapy Market Size, Share and Global Trend by Product Type

AATD Augmentation Therapy Market Size, Share and Global Trend by Product Type

The global alpha-1 antitrypsin deficiency (AATD) augmentation therapy market has been boosted by recent FDA approval for Prolastin-C. According to a report published by Fortune Business Insights, titled “AATD Augmentation Therapy Market: Global Analysis, Insights and Forecast, 2019-2026”, the market will be valued at US$ 1959.8 Mn by the end of 2025. The estimated rise in market value from its 2017 value of US$ 1115.5 Mn implies that the market will exhibit a CAGR of 5.9% in the forecast period. Fortune Business Insights expects that factors such as regulatory approvals and improvements in augmentation therapies will drive the market in this period.

Sample Pages: https://www.fortunebusinessinsights.com/enquiry/sample/aatd-augmentation-therapy-100169

Grifols SA’s AlfaCare Program Has Had a Positive Impact on the Global Market

In November 2018, Grifols Sa introduced AlfaCare, a therapy program aimed at providing training and counselling to patients diagnosed with AATD. Grifols stated that with AlfaCare, it aims to encourage new habits in AATD patients and help them manage their disease properly. Research studies have proven that a huge percentage of people diagnosed with AATD were unaware about the symptoms, effects, and ways to treat the disorder. AlfaCare was launched to overcome all such shortcomings and improve the quality of patient care, thereby ascertaining reduced fatality rate of AATD. Thus, AlfaCare has transformed AATD augmentation therapies worldwide and is likely to boost the global AATD augmentation therapy market in the forecast period.

North America to Dominate the Global Market

Rising number of AATD cases in North America is fuelling the demand for AATD augmentation therapy in this region. This in turn has led to the growth of AATD augmentation therapy market in North America and is likely to favor growth of the market in this region through the forecast period. There have been significant improvements in AATD diagnostic techniques used in many parts of Asia Pacific. Furthermore, the emphasis on AATD by the government in Asia Pacific is likely to enable growth in the regional market in the forthcoming years. Despite North America’s dominance, Asia Pacific will emerge as the fastest growing region in the forecast period.

Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/aatd-augmentation-therapy-100169

New Biological Approval for Prolastin C to Enable Growth of Global Market

In September 2017, Grifols received biologics license approval for Alpha-1 Proteinase Inhibitor to add a new liquid formulation to the currently licensed Prolastin C. The inclusion of this liquid may enable the launch of an additional alternative to the existing therapy. Clinical trials and proven efficacy have favored the approval for this product. With the latest addition to its product portfolio, Grifols will increase its stronghold in the global AATD augmentation therapy market. As Grifols’ products are used by a huge percentage of the global population, its new product approval will have a direct impact on the global market. Backed by successful therapies and efficient products, Grifols has accounted for the highest share in the global market. Recent product approvals have favoured the company and accounting to this, Grifols is likely to emrge dominant in the forecast period as well.

Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/aatd-augmentation-therapy-100169

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email us: sales@fortunebusinessinsights.com
Website: https://www.fortunebusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AATD Augmentation Therapy Market: Grifols, S.A., Kamada Ltd, Shire plc (Baxalta), and CSL Limited. Grifols accounted for the highest share in terms of revenue in 2018 here

News-ID: 1724775 • Views: 749

More Releases from Fortune Business Insights

Smart Robot Market 2021 Reach Valued At $ 31.11 billion And Grow At A 23.1% CAGR …
Smart Robot Market 2021-2028 New study report ” Smart Robot Market 2021 Global Market Opportunities, Challenges, Strategies, and Forecasts 2028″ has been added to Fortune Business Insights. Market Overview- The global smart robot market size is expected to reach USD 31.11 billion by 2027, exhibiting a CAGR of 23.1% during the forecast period. Rapid industrialization coupled with intelligent infrastructure projects will contribute positively to the growth of the market, states Fortune Business Insights,
Competitive Intelligence Tools Market 2021 Net Worth is US$ 82.0 million and For …
Competitive Intelligence Tools Market 2021-2028 New study report ” Competitive Intelligence Tools Market 2021 Global Market Opportunities, Challenges, Strategies, and Forecasts 2028″ has been added to Fortune Business Insights. Market Overview- The global competitive intelligence tools market size is expected to reach USD 82.0 million by 2027, exhibiting a CAGR of 10.3% during the forecast period. The digital transformation coupled with heavy investment in analytics by companies can have an incredible effect
360 Degree Feedback Software Market 2021 Industry Analysis BY Key Players - Peop …
360 Degree Feedback Software Market 2021-2028 New study report ” 360 Degree Feedback Software Market 2021 Global Market Opportunities, Challenges, Strategies, and Forecasts 2028″ has been added to Fortune Business Insights. Market Overview- The global 360 Degree feedback software market is set to gain traction from the rising need to determine the level of employee engagement. As per the State of the Global Workplace report, if employees are unsatisfied or unhappy at the
Payment Processing Solutions Market 2021 Estimated To Grow At 11.7% CAGR and For …
Payment Processing Solutions Market 2021-2027 New study report ” Payment Processing Solutions Market 2021 Global Market Opportunities, Challenges, Strategies, and Forecasts 2027″ has been added to Fortune Business Insights. Market Overview- The global payment processing solutions market size is expected to showcase an exponential growth by reaching USD 116.17 billion by 2027. This is attributable to the increasing adoption of value-added services by major Fintech firms, along with the growing demand for payments

All 5 Releases


More Releases for AATD

Alpha-1 antitrypsin deficiency (AATD) Market 2020 Overview by Experts to 2026
Alpha-1 antitrypsin deficiency (AATD) Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Alpha-1 antitrypsin deficiency (AATD) Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of
Alpha-1 Antitrypsin Deficiency (AATD) Pipeline Insight Market Research Report 20 …
Alpha-1 Antitrypsin Deficiency (AATD) Pipeline Insight, 2020, report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Alpha-1 antitrypsin deficiency pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global coverage Alpha-1 antitrypsin deficiency Understanding Alpha-1 antitrypsin deficiency:
How COVID-19 Impacting On Alpha-1 Antitrypsin Deficiency (AATD) Treatment Global …
Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market 2020 - 2026 includes systematic information regarding to Alpha-1 Antitrypsin Deficiency (AATD) Treatment Industry. Report provides Alpha-1 Antitrypsin Deficiency (AATD) Treatment Industry and provides statistics and information on market dynamics, growth factors, key challenges, major drivers and restraints, opportunities and forecast 2026. To know How COVID-19 Pandemic Will Impact This Market/Industry -Request a sample copy of the report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/alpha-1-antitrypsin-deficiency-aatd-treatment-market-100189 Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market Size,
How COVID-19 Impacting Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market? T …
Report Analyzes Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market Size, Share and Global Trend By Drug Class (Alpha-1 proteinase inhibitor, Bronchodilators, Steroids, Antibiotics), By Route of Administration (Oral, Injection, Inhalation), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores), and Geography Forecast till 2026. Get Sample Report To Know The Impact of Covid19 on this Industry at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/alpha-1-antitrypsin-deficiency-aatd-treatment-market-100189 Key Players: Grifols S.A, CSL Limited, Baxter, Kamada Ltd, Takeda, Abeona Therapeutics. An Overview of the
Increasing use of immunoglobulin in therapeutic areas and prevalence of emphysem …
Plasma fractionation is a process of separating various components of plasma. It is used in prevention and treatment of life-threatening diseases caused by trauma, immunologic disorders, and infections. Plasma fractionation process is used in treating protein deficiency in healthcare applications. It is also used in the production of packaging material for industrial applications. The removal or inactivation of viruses and prions is a prime function of plasma fractionation. Get the Sample
Alpha- Antitrypsin Deficiency (AATD) – Market Insights, Epidemiology and Marke …
DelveInsight’s ‘Alpha Antitrypsin Deficiency – Market Insights, Epidemiology, and Market Forecast-2023’ report provides an overview of the Alpha Antitrypsin Deficiency and global market size of the Alpha Antitrypsin Deficiency for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan. The Report provides a comprehensive review of the market trends, drivers, barriers, key company profiles including its business and product developments. Alpha Antitrypsin Deficiency is the